EDGAR Filing Documents for 0001564590-17-016522

Form 8-K - Current report:

SEC Accession No. 0001564590-17-016522

Filing Date

2017-08-08

Accepted

2017-08-08 16:12:43

Documents

Period of Report

2017-08-08

Items

Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K Q217 EARNINGS PRESS RELEASE	aimt-8k_20170808.htm	8-K	29477
2	EX-99.1	aimt-ex991_123.htm	EX-99.1	139238
3	GRAPHIC	g201708081831187752144.jpg	GRAPHIC	8124
	Complete submission text file	0001564590-17-016522.txt		181288

Mailing Address 8000 MARINA BOULEVARD SUITE 300 BRISBANE CA 94005-1884

Business Address 8000 MARINA BOULEVARD SUITE 300 BRISBANE CA 94005-1884 (650) 614-5220

Aimmune Therapeutics, Inc. (Filer) CIK: 0001631650 (see all company filings)

IRS No.: 452748244 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37519 | Film No.: 171014863
SIC: 2834 Pharmaceutical Preparations